Identification of essential genes as a strategy to select a SARS candidate vaccine using a SARS-CoV infectious cDNA.
Almazán
Fernando
F
Centro Nacional de Biotecnología, CSIC, Madrid, Spain.
DeDiego
Marta L
ML
Galán
Carmen
C
Alvarez
Enrique
E
Enjuanes
Luis
L
D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D003001:Cloning, Molecular; D006224:Cricetinae; D018076:DNA, Complementary / Q000378:metabolism; D015195:Drug Design; D005818:Genetic Engineering; D006801:Humans; D008969:Molecular Sequence Data; D045473:Severe acute respiratory syndrome-related coronavirus / Q000235:genetics* / Q000378:metabolism; D045169:Severe Acute Respiratory Syndrome / Q000378:metabolism / Q000517:prevention & control*; D014158:Transcription, Genetic; D014765:Viral Vaccines / Q000737:chemistry*; D014779:Virus Replication
D018076:DNA, Complementary; D014765:Viral Vaccines